Podcasts about Respiratory disease

In episode 59 of Going anti-Viral, Dr Demetre Daskalakis joins host Dr Michael Saag to discuss his career in public health and the turnover in leadership at the US Centers for Disease Control and Prevention (CDC). Dr Daskalakis is an infectious diseases physician who served in leadership roles at the CDC from 2020 to 2025. He was director of the National Center for Immunization and Respiratory Diseases and was previously director of the Division of HIV Prevention at the National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention. In 2022, he was appointed deputy coordinator of the White House response to the mpox outbreak. Dr Daskalakis discusses his career in public health and leadership roles in infectious diseases. Dr Saag and Dr Daskalakis have a detailed discussion about applying lessons learned from the HIV epidemic in the national response to the mpox outbreak and they discuss Dr Daskalakis's role at the CDC in response to the current measles outbreak. They also address ideologic-driven changes at the CDC under the direction of Secretary Robert F Kennedy Jr. and the Department of Health and Human Services including the firing of Dr Susan Monarez and Dr Daskalakis' subsequent resignation. Finally, they discuss the current direction of the CDC and the outlook for public health without scientific leadership. They also discuss the possibility of a renaissance for public health in the future where it can be reimagined to focus on people instead of historic funding paradigms. 0:00 – Introduction1:21 – Career path in public health and leadership in infectious diseases 4:01 – Applying lessons from the HIV epidemic in response to the mpox outbreak9:48 – Transition to CDC and challenges with the new administration13:50 – CDC role in response to the current measles outbreak17:45 – Management of the CDC by Secretary Robert F Kennedy Jr. and the Department of Health and Human Services 21:22 – The firing of Dr Susan Monarez from the CDC and Dr Daskalakis's resignation28:35 – The lack of scientific leadership remaining at CDC and future outlook ResourcesEpisode 50 - How Vaccines Get Approved in the US: The RSV Story and the Role of the ACIP – Dr Yvonne Maldonado__________________________________________________Produced by IAS-USA, Going anti–Viral is a podcast for clinicians involved in research and care in HIV, its complications, and other viral infections. This podcast is intended as a technical source of information for specialists in this field, but anyone listening will enjoy learning more about the state of modern medicine around viral infections. Going anti-Viral's host is Dr Michael Saag, a physician, prominent HIV researcher at the University of Alabama at Birmingham, and volunteer IAS–USA board member. In most episodes, Dr Saag interviews an expert in infectious diseases or emerging pandemics about their area of specialty and current developments in the field. Other episodes are drawn from the IAS–USA vast catalogue of panel discussions, Dialogues, and other audio from various meetings and conferences. Email podcast@iasusa.org to send feedback, show suggestions, or questions to be answered on a later episode.Follow Going anti-Viral on: Apple Podcasts YouTubeXFacebookInstagram...

AABP Executive Director Dr. Fred Gingrich is joined by technical services veterinarians from Merck Animal Health, Dr. Jacque Fusilier and Dr. Dave Sjeklocha to discuss bovine respiratory disease (BRD) in beef cattle. BRD has long been a challenge in the cattle industry but today, we are taking a fresh look. From shifting market dynamics to evolving herd management practices, we explore what is driving BRD today and what steps we need to take to stay ahead. This episode of Have You Herd? is sponsored by Merck Animal Health as part of their sponsorship package for the opening reception at the 2025 AABP Conference in Omaha, Neb. Merck is also the sponsor of the Merck Bovine Veterinary Student Recognition Award which is the AABP Foundation's scholarship program providing nine students scholarships of $10,000 each.  Market influences can impact producers' willingness to provide interventions to manage disease risk. Merck Animal Health partners with Superior Livestock Auction to evaluate the economic impact of providing preconditioning programs for calves including the VAC45 and PrimeVAC programs. The data from 2024 indicates that this preconditioning program added $8.46/cwt compared to non-preconditioned calves.  We also discuss beef-on-dairy crosses and labor challenges in our industry that can impact disease risk. Good animal handling, management and ensuring adequate colostrum delivery and vaccination can decrease BRD risk. Our guests discuss evaluating the risk of arrival calves by calculating shrink, backtags, other tags and evaluating manure consistency. Sjeklocha has a goal of less than 6% shrink. Technological advancements have also played a role in disease monitoring and improving calf health while optimizing labor resources. Veterinarians can play a key role in monitoring disease, providing goals, evaluating records, and training producers and caregivers how to manage stress and improve handling and management of calves.  For more information on the products available for BRD prevention, control and treatment, visit https://MAHCattle.com. 

In this episode of the SMFM Podcast, Dr. Janine Rhoades welcomes Dr. Andrea Edlow to discuss the 2025–2026 respiratory disease season and vaccine recommendations for pregnant patients. They review the major respiratory threats—COVID-19, influenza, RSV, and pertussis—and emphasize the importance of maternal vaccination for both maternal health and infant protection. The conversation covers current vaccine guidance, disparities in vaccine uptake, strategies for effective patient counseling, and best practices for clinic preparedness, including staff education, vaccine stocking, and infection control policies. They also highlight trusted resources for providers and patients to support safe and effective vaccination during pregnancy. Click here for the full episode transcript. For more educational resources, visit education.smfm.org.    Additional Resources: ·        SMFM Resources o   SMFM Fellow Lecture Preparing for Respiratory Virus Season  o   SMFM Podcast Preparing for Annual Respiratory Disease Season  o   Infectious Disease Resources  §  SMFM COVID-19  §  SMFM RSV  §  SMFM Influenza o   SMFM Patient Education Resources  §  Vaccination During Pregnancy  ·        Government Agency Resources:  o   For Clinicians  CDC Respiratory Illnesses Data Channel  CDC Respiratory Disease Season Outlooks  CDC "From Me, To You" Communications Effort (De Mí, Para Ti)  CDC "Wild to Mild" Social Media Toolkit  HHS "Risk Less, Do More" Campaign for COVID-19, Influenza and RSV Vaccines for Pregnant People  CDC Prenatal Care and Routinely Recommended Vaccinations  CDC 2025 Recommended Immunizations for Adults Aged 19 Years and Older (Full schedule with notes)  CDC MMWR: Influenza, COVID-19 and RSV Vaccination Coverage Among Adults (November 2024)  ·        Peer Organization Resources:  o   For Clinicians  AAFP Immunization Resources  ACNM Immunization Resources  ACOG Immunization Resources  AWHONN Immunization Resources  NPWH Immunization Resources  For Patients  ACOG   MotherToBaby FactSheets MotherToBaby Immunization and Pregnancy Education (En Español)  Vaccinate Your Family  Immunize.org

Grain Report Expectations BRD Treatment Studies Wet or Dry Weather Ahead?   00:01:05 – Grain Report Expectations: K-State grain economist Daniel O'Brien begins today's show by discussing the upcoming USDA Grain Stock and Small Grains report expectations, as well as a positive outlook for corn exports. Daniel O'Brien on AgManager.info   00:12:05 – BRD Treatment Studies: The show continues with David Renter, director of the Center for Outcomes Research and Epidemiology at K-State, as he explains research he and his team have done looking into treatment choices for Bovine Respiratory Disease. Center for Outcomes Research and Epidemiology at K-State   00:23:05 – Wet or Dry Weather Ahead?: Chip Redmond, K-State meteorologist, wraps today's show with his weather forecast, where he expects warmer than normal temperatures and steady weather.     Send comments, questions or requests for copies of past programs to ksrenews@ksu.edu.   Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Shelby Varner and distributed to radio stations throughout Kansas and as a daily podcast.   K‑State Research and Extension is a short name for the Kansas State University Agricultural Experiment Station and Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices, experiment fields, area Extension offices and regional research centers statewide. Its headquarters is on the K‑State campus in Manhattan

About this episode: The FDA and CDC are tightening eligibility requirements for COVID-19 vaccines this year, pushing effective treatments out of reach for millions of Americans including young children. In this episode: Dr. Fiona Havers, formerly a senior adviser on vaccine policy at the CDC, draws on recent hospitalization rates to identify who is most at risk for severe COVID-19 infection and in need of immunization for protection. Guest: Dr. Fiona Havers, MHS, is an infectious disease physician, a medical epidemiologist, and an expert on vaccine-preventable respiratory diseases and vaccine policy. She previously led the Respiratory Virus Hospitalization Surveillance Network Team at the CDC's National Center for Immunization and Respiratory Diseases. Host: Dr. Josh Sharfstein is distinguished professor of the practice in Health Policy and Management, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Recent FDA, CDC changes to COVID vaccination guidelines lead to confusion—WBAL Covid-19 vaccine license change: 12 key questions answered—Your Local Epidemiologist Despite federal shift, state health officials encourage COVID vaccines for pregnant women—Stateline Transcript information: Looking for episode transcripts? Open our podcast on the Apple Podcasts app (desktop or mobile) or the Spotify mobile app to access an auto-generated transcript of any episode. Closed captioning is also available for every episode on our YouTube channel. Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on Bluesky @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed Note: These podcasts are a conversation between the participants, and do not represent the position of Johns Hopkins University.

On August 27, Health Secretary Robert F. Kennedy Jr. and the White House fired CDC director Susan Monarez after only a month on the job. Right after she was ousted, other senior leaders resigned from the agency, including Demetre Daskalakis, an infectious disease physician and former director of the National Center for Immunization and Respiratory Diseases at the CDC.Dr. Daskalakis speaks with Host Flora Lichtman about the state of the agency and what these developments mean for public health.Guest: Dr. Demetre Daskalakis is the former director of the National Center for Immunization and Respiratory Diseases at the CDC.Transcripts for each episode are available within 1-3 days at sciencefriday.com. Subscribe to this podcast. Plus, to stay updated on all things science, sign up for Science Friday's newsletters.

Dr. Demetre Daskalakis, the recent former head of the National Center for Immunizations and Respiratory Diseases, joins Meidas Health for a powerful discussion on why he chose to resign from his post last week and what most concerns him about the future of the nation's public health. Learn more about your ad choices. Visit megaphone.fm/adchoices

Today's West Coast Cookbook & Speakeasy Podcast for our especially special Daily Special, Smothered Benedict Wednesday is now available on the Spreaker Player!Starting off in the Bistro Cafe, MAGA leaders in Congress instantly folded during a contentious cross examination at a heated hearing about Trump's cover up of his dark past.Then, on the rest of the menu, the just-resigned director of the CDC's National Center for Immunization and Respiratory Disease, accused Robert F Kennedy Jr of promoting eugenics; concerns about possible deportation are at the top of the mind as Oregon's roughly half million students return to their classrooms; and, Trump is moving the Space Command from its fortified base buried deep in the Rocky Mountains, to an area out in the open in the Redneck Riviera of Alabama.After the break, we move to the Chef's Table where NATO is working to thwart Russian jamming of civilian flights, two days after a jet carrying European Commission President Ursula von der Leyen was targeted; and, the shooting death of an Indonesian diplomat in Peru is being investigated as a contract killing.All that and more, on West Coast Cookbook & Speakeasy with Chef de Cuisine Justice Putnam.Bon Appétit!The Netroots Radio Live Player​Keep Your Resistance Radio Beaming 24/7/365!“It may be safely averred that good cookery is the best and truest economy, turning to full account every wholesome article of food, and converting into palatable meals what the ignorant either render uneatable or throw away in disdain.” - Eliza Acton ‘Modern Cookery for Private Families' (1845)Become a supporter of this podcast: https://www.spreaker.com/podcast/west-coast-cookbook-speakeasy--2802999/support.

President Trump tests the boundaries of his presidential power after ousting top officials at key agencies. Dr. Demetre Daskalakis, the former director of the CDC's National Center for Immunization and Respiratory Diseases, joins Meet the Press NOW to discuss what prompted his decision to leave the health agency. The families of the two children killed in the Minneapolis church shooting speak out as the community continues to grapple with the tragic event.

Dr. Demetre Daskalakis, who resigned in protest from his position as director of the National Center for Immunization and Respiratory Diseases, talks with Jen Psaki about the valuable work being done by the people at the CDC, and how the Trump administration, through HHS Secretary Robert F. Kennedy Jr., is corrupting the CDC with unscientific attitudes and agendas.Jen's Version: Jen Psaki answers questions posed in today's White House press briefing, without the Trump administration's spin, and doubles down on her criticism of the Trump White House for taking no action to prevent gun violence and instead wasting time on "bad faith back-and-forth."Plus, Philadelphia D.A. Larry Krasner on Donald Trump's use of the military as domestic police, and Graham Platner on challenging Susan Collins for Maine's Senate seat.

Since the late 1800s, producers have battled Bovine Respiratory Disease. Dr. David Prentice joins us today for a modern look at this issue.

AABP Executive Director Dr. Fred Gingrich is joined by Dr. Lilli Heinen, a 2024 Kansas State University College of Veterinary Medicine graduate and dual PhD program, currently employed as a senior researcher at Midwest Veterinary Services, Dr. Brian Lubbers, interim department head in clinical sciences at Kansas State University, and Dr. Ron Tessman, a beef technical consultant at Elanco Animal Health.  This podcast is sponsored by Elanco Animal Health, manufacturers of PradalexTM. The development of Pradalex highlights their commitment to improving animal health outcomes, reducing the risk of resistance and minimizing disruption to animals' normal health biome. Pradalex's structural differences result in a dual-targeting effect, yielding up to 3x better in vitro potency compared to similar fluoroquinolone antibiotics approved for the treatment of BRD. Elanco, a global leader in animal health, is committed to supporting the success of the beef industry by providing resources to help manage health, enhance economic performance, and promote operational sustainability. For more information visit Elanco.com or contact your local Elanco representative.  We begin with an explanation of the mechanism of action of this new antibiotic and the reasons for performing this study. The primary study objective was to evaluate the effect of 3-, 6- and 9-day post-treatment intervals on first treatment success and case fatality in naturally occurring bovine respiratory disease (BRD) in stocker calves. Secondary outcomes included days-to-death (DTD) in the same population. The average overall first treatment success was 61.8% with no statistical differences across the three post-treatment intervals. The average case fatality rate was 12.3% with no statistical differences between the treated groups. The authors note that the population studied was stocker cattle which may have explained the higher numbers compared to feedlot cattle reports. We also discuss the inclusion of DTD in this study and the reasons for this outcome variable.  Veterinarians can utilize this information to guide treatment protocols when using pradofloxacin. Post-treatment intervals are an important component of antimicrobial stewardship as well as decreasing treatment costs without impacting animal health. The Bovine Practitioner is the peer reviewed journal of the American Association of Bovine Practitioners. It is open access and does not charge authors a publication fee. You can find the journal at this link.  Evaluation of 3-, 6- and 9-day post-treatment intervals following pradofloxacin for treatment of bovine respiratory disease in stocker cattle. (2025). The Bovine Practitioner, 59(2), 47-52. https://doi.org/10.21423/bpj20259263 

Corn Production Issues and Yield Potential Bovine Respiratory Disease in Calves Delayed Tomato Harvest   00:01:05 – Corn Production Issues and Yield Potential: Tina Sullivan and Logan Simon, K-State Extension agronomists, begin the show as they explain the unique issue of corn not tasseling and how to estimate yield potential. Corn Production: Pollination Issues and Tightly Wrapped Tassels Corn Production: Estimating Yield Potential   00:12:05 – Bovine Respiratory Disease in Calves: The show continues with Beef Cattle Institute's Brad White and Bob Larson on their recent Bovine Science podcast, where they discuss bovine respiratory disease in calves prior to weaning. Herd Health: Preweened BRD   00:23:05 – Delayed Tomato Harvest: K-State Research and Extension horticulture agent for Riley County, Gregg Eyestone, finishes the show as he says the weather may be pushing back this year's tomato harvest.     Send comments, questions or requests for copies of past programs to ksrenews@ksu.edu.   Agriculture Today is a daily program featuring Kansas State University agricultural specialists and other experts examining ag issues facing Kansas and the nation. It is hosted by Shelby Varner and distributed to radio stations throughout Kansas and as a daily podcast.   K‑State Research and Extension is a short name for the Kansas State University Agricultural Experiment Station and Cooperative Extension Service, a program designed to generate and distribute useful knowledge for the well‑being of Kansans. Supported by county, state, federal and private funds, the program has county Extension offices, experiment fields, area Extension offices and regional research centers statewide. Its headquarters is on the K‑State campus in Manhattan

Diana Stanley, Deputy Editor at The Lancet Respiratory Medicine, is joined by Dr Joan Soriano to discuss a new series on the global epidemiology of respiratory disease, exploring the diagnostic challenges, global trends, and future directions for prevention.Read the full Series:https://www.thelancet.com/series-do/global-epidemiology-chronic-respiratory-disease?dgcid=buzzsprout_icw_podcast_lanrescrd25_lanresContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Send us a textDr. Marc Salzberg, MD is President, Chief Executive Officer & Chief Medical Officer of Airway Therapeutics ( https://www.airwaytherapeutics.com/ ), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases.Dr. Salzberg has more than 25 years of academic and pharmaceutical experience in the management of drug development and clinical research, including medical management of anti-viral drugs clinical development and market introduction including saquinavir and ganciclovir. He spent several years at Roche's headquarters in Basel, Switzerland as well as its affiliate in Toronto, Canada. As Head of Clinical Cancer Research at the Basel University, he co-founded and managed a clinical research network in Switzerland (CCRC).During his career, Dr. Salzberg has successfully managed the growth and acquisition of two contract research organizations benefitting shareholders. He was a founder and President of Pharma Brains, a European boutique CRO, which has been acquired by Medpace, a US based global CRO, after 10 years of successful growth under his leadership. He then served as Vice President of Medical Affairs at Medpace.Dr. Salzberg earned his Medical Doctorate degree from the University of Basel, Switzerland. His medical training and practice include pediatrics/ neonatology and oncology.#MarcSalzberg #AirwayTherapeutics #HumanSurfactantProteinD #Collectin #PathogenRecognition #RespiratoryDiseases  #InflammatoryResponse #BronchopulmonaryDysplasia #ZelpultideAlfa #Covid #Asthma #COPD #Influenza #RSV #ARDS #AcuteRespiratoryDistressSyndrome #ChronicObstructivePulmonaryDisease #ProgressPotentialAndPossibilities #IraPastor #Podcast #Podcaster #ViralPodcast #STEM #Innovation #Technology #Science #ResearchSupport the show

Send us a textIn this episode of Causes or Cures, Dr. Eeks chats with immunology expert Dr. Maziar “Maz” Divangahi about how a fiber found in mushrooms may help us beat the flu, and he introduces us to the concept of disease tolerance. What We'll CoverBeta-Glucan 101What it is: a natural fiber in the outer wall of fungi (think mushrooms).Why it matters: mounting evidence says it can help you fight off the flu by improving something called disease tolerance. Two Immune PlaybooksHost Resistance: the classic “seek and destroy” tactic.Disease Tolerance: a quieter, damage-control strategy our bodies use to stay functional even when a pathogen sticks around.Dr. Maz will unpack how beta-glucan may tilt the balance toward disease tolerance.From TB Labs to Flu ResearchInsights from Dr. Maz's tuberculosis studies that set the stage for his beta-glucan–flu work.Early data on how this fungal fiber might boost flu-specific disease tolerance.Should We Eat More Mushrooms or Supplement?Practical tips and caveats on dietary vs. supplemental beta-glucan.What the current evidence actually supports.Beyond Infections: Beta-Glucan in Cancer TrialsSnapshot of ongoing studies in breast and bladder cancer.Why disease tolerance is a hot oncology frontier.Future Directions & Take-Home PointsWhere Dr. Maz's research is headed next.Simple, science-backed actions listeners can try today.Listen If You've Ever Wondered…Why some people sail through the flu while others end up in the ER.Whether “disease tolerance” might rewrite how we tackle pandemics.If tossing extra shiitakes into your stir-fry can really make a difference.Dr. Maziar (Maz) Divangahi is a Professor of Medicine at McGill University. He is the Associate Director of the Meakins-Christie Laboratories and the Associate Director of the McGill Interna onal TB Centre. He is an internationally recognized pulmonary immunologist and the overarching focus of his research program is to inves gate the regulatory mechanisms involved in host resistance and disease tolerance against major pulmonary bacterial (Mycobacterium tuberculosis) and viral (influenza virus and SARS-CoV2) pathogens. He is currently inves ga ng how to harness the power of innate memory response (Trained Immunity) in vaccine development. Throughout his career, he has been a prolifera ve inves gator publishing in outstanding journals and received numerous awards, including a CIHR New Inves gator Award, FRQS Award, and the CIHR Founda on grant. His scholarly work has been recognized by elec on to the Royal Society of Canada. He is currently holding the Strauss Chair in Respiratory Diseases. You can contact Dr. Eeks at bloomingwellness.com.Follow Eeks on Instagram here.Or Facebook here.Or X.On Youtube.Or TikTok.SUBSCRIBE to her monthly newsletter here! (Now featuring interviews with top experts on health you care about!)Support the show

Chronic respiratory diseases such as chronic obstructive pulmonary disease and asthma are on the rise in many countries, including low-income and middle-income countries such as Kenya that also have a sizeable burden of tuberculosis. What does this mean for patients in terms of the affordability of potentially long-term management? How are government-run social health insurance schemes working for individuals and their families? And what might be the individual-level drivers of catastrophic levels of out-of-pocket health expenditure in this population? Listen to first author Dr Stephen Mulupi and corresponding author Dr Tom Wingfield discuss the nuances of their cross-sectional survey in public health-care facilities in Meru County, Kenya and what they mean for government policy going forward.Read the article:https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(25)00061-0/fulltext?dgcid=buzzsprout_icw_podcast_June_25_langloContinue this conversation on social!Follow us today at...https://thelancet.bsky.social/https://instagram.com/thelancetgrouphttps://facebook.com/thelancetmedicaljournalhttps://linkedIn.com/company/the-lancethttps://youtube.com/thelancettv

Barry Quart, CEO of Connect Biopharma, is developing the next generation of monoclonal antibodies targeting inflammatory respiratory diseases such as COPD and asthma. Administered subcutaneously, their lead program targets IL-4 and has demonstrated the ability to rapidly improve airway function and reduce the incidence of acute exacerbations in these patients. Current treatments rely on steroids and bronchodilators, which do not address the underlying inflammatory causes, an area that has largely been under-addressed by other biologic developers. Barry explains, "Connect has been dedicated for quite a few years to designing next-generation monoclonal antibodies targeting inflammatory diseases. I joined the company last year and really kind of turned the ship towards a sole focus on our lead program, which is rademikibart, a second-generation Dupixent, a monoclonal antibody targeting IL-4, a really important target for certain inflammatory diseases." "IL-4 can be used as a monoclonal antibody targeting IL-4 for diseases such as atopic dermatitis, asthma, and COPD, as well as several other conditions. We're focused on asthma and COPD. So, inflammatory respiratory disease, because our product has some unique characteristics that are going to allow us to focus on an area that's really been completely ignored by other developers of biologics in the respiratory space, and specifically on patients having acute exacerbations."  #ConnectBiopharma #MonoclonalAntibody #IL4 #COPD #Asthma #AtopicDermatitis #InflammatoryDiseases #RespiratoryDiseases connectbiopharm.com Download the transcript here

Barry Quart, CEO of Connect Biopharma, is developing the next generation of monoclonal antibodies targeting inflammatory respiratory diseases such as COPD and asthma. Administered subcutaneously, their lead program targets IL-4 and has demonstrated the ability to rapidly improve airway function and reduce the incidence of acute exacerbations in these patients. Current treatments rely on steroids and bronchodilators, which do not address the underlying inflammatory causes, an area that has largely been under-addressed by other biologic developers. Barry explains, "Connect has been dedicated for quite a few years to designing next-generation monoclonal antibodies targeting inflammatory diseases. I joined the company last year and really kind of turned the ship towards a sole focus on our lead program, which is rademikibart, a second-generation Dupixent, a monoclonal antibody targeting IL-4, a really important target for certain inflammatory diseases." "IL-4 can be used as a monoclonal antibody targeting IL-4 for diseases such as atopic dermatitis, asthma, and COPD, as well as several other conditions. We're focused on asthma and COPD. So, inflammatory respiratory disease, because our product has some unique characteristics that are going to allow us to focus on an area that's really been completely ignored by other developers of biologics in the respiratory space, and specifically on patients having acute exacerbations."  #ConnectBiopharma #MonoclonalAntibody #IL4 #COPD #Asthma #AtopicDermatitis #InflammatoryDiseases #RespiratoryDiseases connectbiopharm.com Listen to the podcast here

AABP Executive Director Dr. Fred Gingrich reviews a paper published in The Bovine Practitioner with the first author Madeline Mancke from Kansas State University. The objective of this study was to determine potential associations between Cardiac Troponin I (cTnI) serum concentration of cattle at initial bovine respiratory disease (BRD) treatment with the risk of retreatment or mortality at 60 days. BRD is the most significant disease in beef cattle and is a major cause of morbidity and mortality. Developing prognostic tools may be valuable for managing individual cases. cTnI is a protein that is released into the circulatory system after myocardial damage and may be useful as a biomarker for prognostication of BRD cases. Mancke walks through the results of the paper which demonstrated that 8/318 samples had high cTnI levels and animals with high cTn1 concentrations had a significantly greater probability of not finishing the 60-day post-enrollment period. Cattle with high cardiac troponin concentrations at initial BRD treatment were more likely to have negative clinical outcomes but, in this study, very few animals had high cTnI levels. Mancke provides information about potential future research opportunities to better manage BRD cases in the feedyard.  The Bovine Practitioner is the peer-reviewed journal published by AABP. The journal publishes original research, case studies, review articles and case studies that are intended to provide information to the practicing cattle veterinarian. The journal is available open-access online and print volumes are available for purchase. There are no publication fees for authors and the peer review and submission process is managed online. Find the journal at this link.  Evaluation of cardiac troponin I as a predictor of clinical outcomes in cattle treated for bovine respiratory disease (BRD) in commercial feedyards. Bov Pract. 2025;59(1), 24-28. https://doi.org/10.21423/bpj20259053 

When you're in an environment where the air is dry, a whole cascade of responses renders you more susceptible to respiratory conditions and diseases. That's according to research by respiratory health expert David Edwards at Johns Hopkins. Edwards: It's understood … How are dry air and respiratory disease connected? Elizabeth Tracey reports Read More »

Dr. Zach Bush, a renowned physician and regenerative farming advocate, discusses the importance of soil health on human and pet health. He explains that 97% of global soils are depleted, leading to nutrient-poor crops and chronic diseases. He emphasizes regenerative farming practices that focus on biodiversity and soil health, which can restore soil fertility and improve crop yields. Dr. Zach also introduces his product, ION, derived from ancient fossil soils, which enhances cellular communication and mitochondrial metabolism, promoting health and longevity in both humans and pets. Dr. Judy Morgan shares her personal experience with soil and farming challenges, highlighting the need for better soil management and nutrition for pets. So much great, great information! ZBMD http://zachbushmd.com/ ION* https://intelligenceofnature.com/ FARMER'S FOOTPRINT: http://www.farmersfootprint.us/ THE JOURNEY OF INTRINSIC HEALTH: https://journeyofintrinsichealth.com/ PRODUCT SPOTLIGHT #1 As their trusted guardians we are responsible for Keeping our pets safe from harm. In today's world that's getting harder than ever. Unfortunately, our pets are constantly exposed to damaging and virtually unavoidable toxins like glyphosate. This exposure weakens their immune systems, causes inflammation and disrupts the microbiome. One of the best things you can do to help protect your pet is to ensure their natural defenses are at their strongest. That's where ION Gut Support for Pets can help. ION Gut Support for Pets is proven to strengthen the gut lining within minutes, supporting your pet's innate ability to defend against toxins, while promoting healthy digestion, immune function and kidney health. We can't remove the world's harmful toxins, but we can help make living in it safer for our loved ones, especially the furry ones who entrust us with their care. Try ION Gut Support for Pets today. Order now at intelligenceofnature.com and save 15% off your first order of ION with the code DRJUDY. Please note that Naturally Healthy Pets may receive a commission on any orders placed with our code. PRODUCT SPOTLIGHT #2 Respiratory Diseases in dogs can cause significant distress. They include laryngeal paralysis, collapsing trachea, pulmonary fibrosis, chronic bronchitis, infectious disease, cancer, tumors, heart disease. Luckily, integrative veterinarian Dr Judy Morgan has created a comprehensive short course that addresses common respiratory diseases and how to use traditional Chinese Veterinary Medicine, food therapy, supplements and hands on care to ensure your pet retains a vibrant life. Podcast listeners can take advantage of 20% off of Respiratory Diseases in Dogs by using the code PODCAST54 when ordering on DrJudyU.com.

The National Cancer Institute is exploring a new new tech-based treatment to help patients overcome a severe breathing disorder caused by the Human Papilloma Virus. Leaders from the agency's Center for Cancer Research — Dr. Clint Allen, a senior investigator, and Dr. Scott Norberg, an associate research physician — join us to discuss the findings from their recent study on the Recurrent Respiratory Papillomatosis, which can cause damage to the vocal cords and block airways, making it hard to breathe. Allen and Norberg shared details about the therapy, which uses a gorilla adenovirus based-technology to target the infection.

A vet shares the latest on transmission, prevention, and what pet owners should look out for to keep their dogs healthy and safe

A vet shares the latest on transmission, prevention, and what pet owners should look out for to keep their dogs healthy and safe

Dr. Luke Strehle of Nebraska Vet Services, a full-service mixed animal practice based in West Point, Nebraska, joins us to share his insight on swine respiratory pathogens – how to reduce and eliminate their risk as well what interventions are available to manage pig health. This episode is brought to you by Pharmgate Animal Health, a growing business that puts livestock first. Pharmgate provides a proven portfolio of technically supported, high-quality products that are the foundation of custom herd health protocols. By offering multiple options for active ingredients, concentrations, and administration routes, Pharmgate provides you with choices to fit your needs backed by a team with technical expertise to get the results you want.

Vaccinations play an important role in both our individual and community health. They help to prevent serious and sometimes deadly diseases by strengthening our immune system. But in recent years this cost effective method of disease prevention has come under the spot light, drawing attention to some myths and misconceptions. In this episode, Dr Anne von Gottberg dives into the importance of vaccinations, how to handle missed vaccines, vaccine dos and don'ts and recent changes in the Extended Programme onIimmunzation(EPI) in South Africa.About our Guest: Dr Anne von Gottberg is currently the laboratory lead at the Centre for Respiratory Diseases and Meningitis at the National Institute for Communicable Diseases, Johannesburg, South Africa; and Associate Professor within the School of Pathology, Faculty of the Health Sciences, University of the Witwatersrand, Johannesburg; and Honorary Professor, Department of Pathology, Faculty of Health Sciences, University of Cape Town, Cape Town. She leads a laboratory team responsible for reference diagnostics for respiratory and meningitis pathogens nationally and regionally. The laboratory is the regional reference laboratory for the World Health Organization (WHO) Vaccine-preventable Invasive Bacterial Diseases (VP-IBD) Coordinated Global Surveillance Network for the southern African region; a National Influenza Centre (NIC); and a global WHO RSV and regional SARS-CoV-2 reference laboratory. She is currently a member of several committees and technical advisory groups for AFRO, Africa CDC and WHO. Her main interests include surveillance for meningitis and respiratory pathogens, assessing vaccine effectiveness where relevant. She has authored or co-authored more than 200 articles in peer-reviewed journals. In addition, she supervises a number of Masters and PhD students. Dr von Gottberg obtained her MBBCh and PhD at the University of the Witwatersrand, and trained for her specialisation in clinical microbiology (FC Path[SA] MICRO) at the National Health Laboratory Service (former South African Institute for Medical Research) and at the University of the Witwatersrand.WE'D LOVE YOUR FEEDBACK ON THIS EPISODE – Visit the Microbe Mail website to sign up for updates Follow on:Instagram: Microbe_MailX/Twitter: @microbemailFacebook: MicrobeMailTiktok: @microbe.mailWatch this episode on our new YouTube channel: Microbe MailE-mail us: mail.microbe@gmail.com

Join Tanya Laidlaw, MD, FAAAAI, for a detailed and insightful conversation about the pathophysiology of AERD as well as the diagnosis and current management strategies.  

Joining us for this episode of Feedstuffs in Focus is Dr. David Baumert, Senior Technical Services Veterinarian at Zoetis Pork, to discuss the reasons why producers sometimes choose not to treat pigs — usually heavier weight finishers — in need of swine respiratory disease (SRD) therapy and the implications of non-use from a performance, labor and economic standpoint. This episode of Feedstuffs in Focus has been brought to you by Zoetis Pork.IMPORTANT SAFETY INFORMATION: People with known hypersensitivity to penicillin or cephalosporins should avoid exposure to EXCENEL RTU EZ. Do not use in swine found to be hypersensitive. Withdraw 6 days prior to slaughter when injection site volumes are greater than 5 mL up to 15 mL per injection site and 4 days prior to slaughter when injection site volumes are less than or equal to 5 mL per injection site. See full Prescribing Information at Excenelpork.com/PI.ReferencesPantoja L, Kuhn M, Farrand E, et al. Impact of a Husbandry Education Program on nursery pig mortality, productivity, and treatment cost. Journal of Swine Health and Production [serial online]. 2013;21 (4):188-194. Available from: CAB Abstracts, Ipswich, MA. Accessed May 1, 2018. Pineiro C, Morales J, Doncecchi P, et al. Individual Pig Care program improves productive performance and animal health in nursery-growing pigs. Journal of Swine Health and Production [serial online]. 2014;22 (6):296-299. Available from: CAB Abstracts, Ipswich, MA. Accessed August 1, 2018.Bowersock, T. L., Meeuwse, D. M., Kausche, F. M., Lucas, M. J., Bryson, W. L. and Dame, K.J. Efficacy of ceftiofur crystalline free acid and ceftiofur hydrochloride administered intramuscularly in swine inoculated with Actinobacillus pleuropneumoniae. Pharmacia Animal Health. 2001. Data on file, Study Document No. ZRD-PSC-004402, Zoetis Inc.All trademarks are the property of Zoetis Services LLC or a related company or a licensor unless otherwise noted. © 2024 Zoetis Services LLC. All rights reserved. EXC-00084

Guidelines from the American Thoracic Society report on the value of pulmonary rehabilitation for people with COPD, interstitial lung disease, or pulmonary hypertension. JAMA Clinical Guidelines Synopsis author Michaela R. Anderson, University of Pennsylvania, discusses these guidelines and more with JAMA Associate Editor David Simel, MD, MHS. Related Content: Pulmonary Rehabilitation for Adults With Chronic Respiratory Disease Proper Use of Inhalant Medications for Chronic Respiratory Diseases

Infectious upper respiratory disease, or I-U-R-D, is a scourge to kittens — especially those…

Infectious upper respiratory disease, or I-U-R-D, is a scourge to kittens — especially those in multi-cat situations. Beyond targeting the respiratory tract, the pathogens — like herpesvirus — can cause...

NEWS: DOH warns of more respiratory diseases | Jan. 9, 2025Visit our website at https://www.manilatimes.netFollow us:Facebook - https://tmt.ph/facebookInstagram - https://tmt.ph/instagramTwitter - https://tmt.ph/twitterDailyMotion - https://tmt.ph/dailymotionSubscribe to our Digital Edition - https://tmt.ph/digitalSign up to our newsletters: https://tmt.ph/newslettersCheck out our Podcasts:Spotify - https://tmt.ph/spotifyApple Podcasts - https://tmt.ph/applepodcastsAmazon Music - https://tmt.ph/amazonmusicDeezer: https://tmt.ph/deezerStitcher: https://tmt.ph/stitcherTune In: https://tmt.ph/tunein#TheManilaTimes Hosted on Acast. See acast.com/privacy for more information.

IDSA President Tina Tan, MD, FIDSA, FPIDS, FAAP, discusses the 2024-2025 respiratory illness season with Brendan Jackson, MD, MPH, Director of the Office of Readiness, Response and Operations at the CDC National Center for Immunization and Respiratory Diseases.

Jeffrey Ekoma, ASTHO Senior Director for Government Affairs, tells us what to expect from Congress as the year wraps up; Dr. Brendan Jackson, Director of the Office of Readiness, Response, and Operations for the CDC's National Center for Immunization and Respiratory Diseases, discusses the current state of respiratory virus season as we wrap up National Influenza Vaccination Week; and ASTHO has compiled a number of evidence-based technical packages for your use. ASTHO Web Page: Stay Informed CDC Web Page: About National Influenza Vaccination Week ASTHO Web Page: Evidence-Based Public Health  

Dando sequência à série "Naruhodo Entrevista" de conversas descontraídas com cientistas brasileiras e brasileiros, chegou a vez da Médica, Doutora em Fisiopatologia em Clínica Médica e Livre Docência em Pneumologia, Suzana Tanni.Só vem!> OUÇA (90min 14s)*Naruhodo! é o podcast pra quem tem fome de aprender. Ciência, senso comum, curiosidades, desafios e muito mais. Com o leigo curioso, Ken Fujioka, e o cientista PhD, Altay de Souza.Edição: Reginaldo Cursino.http://naruhodo.b9.com.br*Suzana Erico Tanni possui graduação em Medicina pela Universidade Estadual Paulista Júlio de Mesquita Filho (1998), doutorado em Fisiopatologia em Clínica Médica [Botucatu] pela Universidade Estadual Paulista Júlio de Mesquita Filho (2008) e Livre Docente em Pneumologia pela Universidade Estadual Paulista Júlio de Mesquita Filho (2018). Atualmente é Professora Associada da Universidade Estadual Paulista Júlio de Mesquita Filho. Foi presidente da Sociedade Paulista de Pneumologia e Tisiologia (2022-2023). Coordenadora da Comissão de Epidemiologia e Pesquisa Clínica da Sociedade Brasileira de Pneumologia e Tisiologia, com responsabilidade na construção de guidelines nacionais de conteúdo respiratório.Desde 2010 atua como Docente do curso MECOR - Methods in Epidemiologic, Clinical and Operations Research da American Thoracic Society e da Associación Latino Americana do Thorax. Atualmente é Docente Líder do nível 2, para realização de manual de procedimento operacionais e plano de análise estatística.É Editora Associada do periódico Jornal Brasileiro de Pneumologia na área de Epidemiologia e DPOC, na Revista Médica Brasileira na área de pneumologia e da Frontiers Medicine-Respiratory Diseases. Atua como "Guest Editor" nos periódicos Frontiers in Case Report in Respiratory Diseases e Women in Science: Pulmonary Medicine 2023.Desde 2008, atua em Estudos Multicêntricos sobre Doenças Respiratórias. Faz parte do 4-Consortium for Clinical Characterization of COVID-19 By EHR (4CE) liderado por pesquisadores da Harvard Medical School, Boston, USATem experiência na área de Medicina, com ênfase em Pneumologia, atuando principalmente no seguinte tema: doenças pulmonares; doença pulmonar obstrutiva crônica, tabagismo e covid-19.Lattes: http://lattes.cnpq.br/4887507894734442*APOIE O NARUHODO PELA PLATAFORMA ORELO!Um aviso importantíssimo: o podcast Naruhodo agora está no Orelo: https://bit.ly/naruhodo-no-oreloE é por meio dessa plataforma de apoio aos criadores de conteúdo que você ajuda o Naruhodo a se manter no ar.Você escolhe um valor de contribuição mensal e tem acesso a conteúdos exclusivos, conteúdos antecipados e vantagens especiais.Além disso, você pode ter acesso ao nosso grupo fechado no Telegram, e conversar comigo, com o Altay e com outros apoiadores.E não é só isso: toda vez que você ouvir ou fizer download de um episódio pelo Orelo, vai também estar pingando uns trocadinhos para o nosso projeto.Então, baixe agora mesmo o app Orelo no endereço Orelo.CC ou na sua loja de aplicativos e ajude a fortalecer o conhecimento científico.https://bit.ly/naruhodo-no-orelo

There is a new convenient, one-shot, low-volume antibiotic from Elanco Animal Health that offers swine respiratory disease treatment protocol flexibility from nursery to finish. Pradalex has a unique structure that differs from any molecule in its class. What opportunities might Pradalex have for your hog operation. Joining us to share his experience and trial work to date with Pradalex is veterinarian Dr. Paul Thomas of AMVC.This episode of Feedstuffs in Focus is brought to you by Elanco Animal Health. Learn more about Elanco at farmanimal.elanco.com/us/swine 

This episode explores how COVID-19 is a systemic disorder affecting multiple organs and the potential therapeutic role of neutralizing micro RNA 2392. It also discusses new findings on the association between serotonin reduction and the neurological and cognitive symptoms in long COVID patients. Looking for the YouTube version? Click here to watch now! Get Functional Diagnostic Nutrition's best workshops and freebies at fdntraining.com/resources.

Respiratory diseases like the flu or RSV are common during the Fall and Winter, but how do you know when your symptoms mean you should seek medical care? And what steps can you take to protect yourself from getting sick in the first place? What is different this fall and winter? And how and when do vaccines get approved anyway? Host Dr. Anne Zink and guests discuss managing respiratory diseases and staying healthy this fall and winter.

Swine respiratory disease (SRD) is a commonly encountered health challenge in today's hog industry. SRD includes a wide range of bacterial pathogens that can impact pig respiratory systems as well as the overall health of a farm system. What might all this mean for your operation, and how can you fight back? This episode is brought to you by Pharmgate Animal Health, a growing business that puts livestock first. Pharmgate provides a proven portfolio of technically supported, high-quality products that are the foundation of custom herd health protocols. By offering multiple options for active ingredients, concentrations, and administration routes, Pharmgate provides you with choices to fit your needs backed by a team with technical expertise to get the results you want.Joining us today on Feedstuffs in Focus is Dr. Nic Lauterbach, technical services veterinarian with Pharmgate Animal Health. Our topic is that of how swine respiratory disease can be stopped in its tracks through the implementation of practical strategies and recommendations for improving herd health outcomes when faced with the threat of swine respiratory disease.To access more SRD resources and connect with an expert, visit Pharmgate.com.

About this episode: Respiratory syncytial virus can be particularly dangerous for older adults and infants and this year, for the first time, there are three approved and readily available products to help prevent severe disease: A vaccine for pregnant women and people over age 65, and an antibody treatment for infants born during RSV season. In this episode: all about these products and they promise they show for dramatically reducing the number of hospitalizations and deaths from RSV this year. Guests: Dr. Georgina Peacock is the director of the Immunization Services Division in the National Center on Immunization and Respiratory Diseases at the CDC. Host: Dr. Josh Sharfstein is vice dean for public health practice and community engagement at the Johns Hopkins Bloomberg School of Public Health, a faculty member in health policy, a pediatrician, and former secretary of Maryland's Health Department. Show links and related content: Surveillance of RSV—CDC Why So Many Babies Didn't Get RSV Vaccines This Winter—Public Health On Call (February, 2024) Contact us: Have a question about something you heard? Looking for a transcript? Want to suggest a topic or guest? Contact us via email or visit our website. Follow us: @‌PublicHealthPod on X @‌JohnsHopkinsSPH on Instagram @‌JohnsHopkinsSPH on Facebook @‌PublicHealthOnCall on YouTube Here's our RSS feed

Recently, a study was conducted at the university of Auckland analysing the use of A.I in predicting the prevalence of respiratory disease outbreaks during flu seasons in Aotearoa. Forecasting models are essential for hospitals in predicting admissions and subsequently allocating resources and beds. However, during peak flu periods, and, most notably the height of the COVID-19 pandemic, hospitals across Aotearoa have been largely underprepared for respiratory disease outbreaks, hence why experts have called for improvements to be made to traditional forecasting models.  Oto spoke to Dr Steffen Albrecht, a Research Fellow at the School of Computer Science at the University of Auckland and author of the study, to talk about the study and how A.I could help disease forecasting models in hospitals across Aotearoa. 

Dr. Brad White of Kansas State University and Director of the Beef Cattle Insitute talks about his team's research into Bovine respiratory disease, or Shipping Fever. Bovine respiratory disease costs ranchers in the United States about $900 million annually due to animal death, reduced feed efficiency and treatment costs. The research represents the most comprehensive assessment of risk factors and pathological characteristics of late day pulmonary disease ever reported, generating valuable results that will help ranchers and veterinarians improve animal welfare, mitigate the negative impacts of this disease while promoting antimicrobial stewardship.

What sickness is going around right now? Is bird flu worse in fall? What is sloth fever? How is cholera transmitted? When is respiratory virus season 2024? AMA's Vice President of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, covers the latest outbreak news today and discusses new viruses going around 2024. American Medical Association CXO Todd Unger hosts.

Dr. Tess Eidem a practitioner and researcher working with the cannabis industry. She is interested in IEQ issues from a very broad perspective such as relative humidity and ventilation to very specific topics such as Bioaerosol exposures when cultivating cannabis. This week we will explore cannabis production, the worker health issues it poses and how we can learn from this new and quickly expanding area. Her most recent paper with Tara Nordgren and Mark Hernandez is on Bioaerosol Exposures and Respiratory Diseases in Cannabis Workers.  Tess Eidem's doctoral research focused on developing novel antibiotics against bacterial pathogens, and her scientific career has centered on bringing modern microbiology and RNA biology practices to promote human health. Leveraging her scientific expertise, Dr. Eidem transitioned into the cannabis industry where she spent four years working directly in cannabis production and quality management. This unique experience allowed her to combine her hands-on skills in manufacturing with microbiology and product safety as a Preventive Controls Qualified Individual (PCQI) to help cannabis cultivators minimize potential hazards within their facilities and in their products. Having witnessed firsthand the challenges of microbial contamination in the cannabis industry, Dr. Eidem returned to the University of Colorado Boulder, where she currently works as a Senior Research Scientist in the Aerobiology and Disinfection Laboratory, with a focus on practical building science. Her research investigates bioaerosol persistence associated with cannabis environments, including airborne molds, allergens, and pathogens. She is driven to connect unbiased scientific research with environmental engineering principles and applying them to the cannabis space to improve worker well-being, plant health, and consumer safety.

AABP Executive Director Dr. Fred Gingrich is joined by Dr. Brad White from the Kansas State University Beef Cattle Institute to discuss a paper published in the Bovine Practitioner titled “Risk factors Associated with Case Fatality and Treatment Success following Initial Bovine Respiratory Disease Treatment in Feedyard Cattle”. This paper was a retrospective analysis of existing feedyard data to identify potential relationships between risk factors known at the time of initial treatment for bovine respiratory disease (BRD) and treatment outcomes. The three post-treatment outcomes evaluated were first treatment success, post-treatment deaths from any cause, and post-treatment deaths due to BRD.  The investigators found the overall first treatment success for BRD to be 67.8% with all-cause mortality of 10% and BRD related mortality of 6.3%. White discusses associations found with each post-treatment outcome evaluated which can be useful information as veterinarians evaluate the success of their BRD treatment, prevention and control protocols for their customers, and define expectations with clients.  Neal, K. B., White, B. J., Amrine, D. E., Lubbers, B. V., Tessman, R. K., & Larson, R. L. (2024). Risk factors Associated with Case Fatality and Treatment Success following Initial Bovine Respiratory Disease Treatment in Feedyard Cattle. The Bovine Practitioner, 58(2), 1–8. https://doi.org/10.21423/bovine-vol58no2p1-8 

In this VETgirl podcast, we interview Dr. Carol Reinero on what's new with CIRDC in dogs. What pathogens cause CIRDC, and how do we protect our canine patients? Tune in as she discusses how to get your “social dogs” protected, how we treat CIRDC, and what kind of tests should be run in isolated cases of suspected CIRD and in suspected outbreaks of CIRD!

Pandemics are on the rise. Will bird flu be next? The government says it's monitoring the situation, but should we worry? According to former National Security Council Director for Medical and Biodefense Preparedness and expert on emerging infectious diseases, Luciana Borio, the answer is yes. Not only because bird flu is dangerous, but because the government may be giving us happy talk. The more you know, the better. So join us.